Virtual TB Intensive Course

Dates: September 16 - October 21
Location: Online

This course for clinicians provides focuses on the application of principles for the diagnosis and treatment of TB infection and TB disease. Topics include transmission and pathogenesis, diagnosis and treatment, case management, cultural competency, and managing side effects of treatment. The format includes live lectures, interactive discussions, and archived presentations.

Course participants are expected to attend a weekly live webinar session. The dates for the live sessions are the following:

  • Thursday, September 16 | 10:00 - 11:15 AM 
  • Thursday, September 23 | 10:00 - 11:15 AM    
  • Thursday, September 30 | 10:00 - 11:15 AM    
  • Thursday, October 7 | 10:00 - 11:15 AM    
  • Thursday, October 14 | 10:00 - 11:15 AM     
  • Thursday, October 21 | 10:00 - 11:15 AM

The course is designed for physicians, nurses, and healthcare professionals who are involved in the diagnosis and management of TB patients. Individuals who work in the following settings would benefit from attending this workshop:

  • TB Programs
  • Health Departments
  • Hospital Infection Control
  • Correctional Facilities
  • Long Term Care Facilities
  • Immigrant & Refugee Health
  • Community Health Settings
  • College or University Health Services

As the incidence of tuberculosis continues to decline, maintaining clinical and public health expertise in TB is particularly challenging. Therefore, ongoing training and education are important for healthcare providers to enhance skills in TB diagnosis, follow recommended treatment guidelines, and interact effectively with public health agencies. This type of training is also important for new clinicians working in TB control or other settings.

Upon completion of this course, participants should be better able to:

  • List approaches for addressing clinical and social challenges in the management of patients with tuberculosis to achieve successful outcomes.
  • Implement recommendations for prompt diagnosis, appropriate treatment and effective management of tuberculosis disease.
  • Apply the latest advances for assessing risk, testing and treating TB infection to prevent development of disease.

This course will build upon basic TB concepts. Prior to the course, it is recommended that participants review the CDC’s Core Curriculum on Tuberculosis: What the Clinician Should Know (Available at: In order to meet the learning objectives and receive continuing education credits, participants are required to attend the entire course, and complete an evaluation form. A post-course follow-up evaluation will be sent within 1 month of the course.

CONTINUING EDUCATION INFORMATION support of improving patient care, this activity has been planned and implemented by Rutgers Biomedical and Health Sciences and the Massachusetts Department of Public Health. Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIANS: Rutgers Biomedical and Health Sciences designates this live activity for a maximum of 11.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSES: This activity is awarded 11.5 contact hours (60-minute CH). Nurses should only claim those contact hours actually spent participating in the activity.


There is no fee to participate in this course. Please click here to apply for this course.. We will review your application and follow-up to confirm your enrollment (please note that space in the course is limited).

For more information, please contact Olivia Dupont at

Funding for this course was made possible in part by the Centers for Disease Control and Prevention. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. government.


Jane Carter, MD
Professor of Medicine

Brown University Warren Alpert

David Cennimo, MD
Assistant Professor of Medicine
Rutgers New Jersey Medical School

Henry Fraimow, MD
Associate Professor of Medicine
Cooper Medical School of Rowan University

Amee Patrawalla, MD
Medical Director
Global Tuberculosis Institute

Alfred Lardizabal, MD
Executive Director
Global Tuberculosis Institute



Olivia Dupont, MPH
Health Educator

Global Tuberculosis Institute

Anita Khilall, MPH
Program Director, Education and Training
Global Tuberculosis Institute

Alfred Lardizabal, MD
Executive Director
Global Tuberculosis Institute

Amee Patrawalla, MD
Medical Director
Global Tuberculosis Institute

Patricia Woods, MSN
Public Health Nurse Consultant
TB Program, New Jersey Department of Health